Summary
Esterases, hydrolases which split ester bonds, hydrolyse a number of compounds used as drugs in humans. The enzymes involved are classified broadly as cholinesterases (including acetylcholinesterase), carboxylesterases, and arylesterases, but apart from acetylcholinesterase, their biological function is unknown. The acetylcholinesterase present in nerve endings involved in neurotransmission is inhibited by anticholinesterase drugs, e.g. neostigmine, and by organophosphorous compounds (mainly insecticides). Cholinesterases are primarily involved in drug hydrolysis in the plasma, arylesterases in the plasma and red blood cells, and carboxylesterases in the liver, gut and other tissues.
The esterases exhibit specificities for certain substrates and inhibitors but a drug is often hydrolysed by more than one esterase at different sites. Aspirin (acetylsalicylic acid), for example, is hydrolysed to salicylate by carboxylesterases in the liver during the firstpass. Only 60% of an oral dose reaches the systemic circulation where it is hydrolysed by plasma cholinesterases and albumin and red blood cell arylesterases. Thus, the concentration of aspirin relative to salicylate in the circulation may be affected by individual variation in esterase levels and the relative roles of the different esterases, and this may influence the overall pharmacological effect. Other drugs have been less extensively investigated than aspirin and these include heroin (diacetylmorphine), suxamethonium (succinylcholine), Clofibrate, Carbimazole, procaine and other local anaesthetics. Ester prodrugs are widely used to improve absorption of drugs and in depot preparations. The active drug is released by hydrolysis by tissue carboxylesterases.
Individual differences in esterase activity may be genetically determined, as is the case with atypical cholinesterases and the polymorphic distribution of serum paraoxonase and red blood cell esterase D. Disease states may also alter esterase activity.
Similar content being viewed by others
References
Aldrige, W.N.: Two types of esterase (A and B) hydrolysing p-nitrophenylactate, propionate and butyrate, and a method of their determination. Biochemical Journal 53: 110–117 (1953).
Ali, B. and Kaur, S.: Mammalian tissue acetylsalicylic acid esterases. Identification, distribution and discrimination from other esterases. Journal of Pharmacology and Experimental Therapeutics 226: 589–594 (1983).
Augustisson, K.B.: Multiple forms of esterase in vertebrate blood plasma. Annals of the New York Academy of Sciences 94: 844–860 (1961).
Bergmann, F.; Segal, R. and Rimon, S.: A new type of esterase in Hog-kidney extract. Biochemical Journal 67: 481–486 (1957).
Bleckman, W.J. and Lechner, B.L.: Clinical comparative evaluation of choline magnesium trisalicylate and acetylsalicylic acid in rheumatoid arthritis. Rheumatology and Rehabilitation 18: 119–124 (1979).
Builder, J.; Landecker, K.; Whitecross, D. and Piper, D.W.: Aspirin esterase of gastric mucosal origin. Gastroenterology 73: 15–18 (1977).
Bundgaard, H. and Hansen, A.B.: Prodrugs as drug delivery systems. Pharmacy International 2: 136–140 (1981).
Costello, P.B.; Caruana, J.A. and Green, F.A.: The relative roles of hydrolases of the erythrocyte and other tissues in controlling aspirin survival in vivo. Arthritis and Rheumatism 27: 422–426 (1984).
Costello, P.B. and Green, F.A.: Aspirin survival in human blood modulated by the concentration of erythrocytes. Arthritis and Rheumatism 25: 550–555 (1982).
Costello, P.B. and Green, F.A: Identification and partial purification of the major hydrolysing enzyme in human blood. Arthritis and Rheumatism 26: 541–547 (1983).
Dreyfuss, J.; Shaw, J.M. and Ross, J.F.: Fluphenazine enanthate and fluphenazine decanoate: Intramuscular injection and es-terification as requirements for slow release characteristics in dogs. Journal of Pharmaceutical Sciences 65: 1310–1315 (1976).
Eckerson, H.W.; Collette, M.; Whyte, C. and La Du, B.N.: The human serum paroxonase/arylesterase polymorphism. American Journal of Human Genetics 35: 1126–1138 (1983a).
Eckerson, H.W.; Romson, J.; Wyte, C. and La Du, B.N.: The human serum paraoxonase polymorphism: Idenficiation of phenolypes by their response to salts. American Journal of Human Genetics 35: 214–227 (1983b).
Gupta, J.D. and Gupta, V.: Serum aspirin esterase activity in women with habitual aspirin uptake. Clinica Chimica Acta 81: 261–265 (1977).
Harris, P.A. and Riegelman, S.: Acetylsalicylic acid hydrolysis in human blood and plasma. I. Methodology and in vitro studies. Journal of Pharmaceutical Sciences 56: 713–716 (1967).
Hopkinson, D.A.; Mestriner, M.A.; Cortner, J. and Hans, H.: Esterase D a new human polymorphism. Annals of Human Genetics 37: 119–137 (1973).
Horai, S. and Matsunaga, E.: Differential enzyme activities in human esterase D phenotypes. Human Genetics 66: 168–170 (1984).
Inoue, M.; Morikowa, M.; Tsubo, M.; Ito, Y. and Sugiura, M.: Comparative study of human intestinal and hepatic esterases as related to enzymatic properties and hydrolysing activity for ester-type drugs. Japanese Journal of Pharmacology 30: 529–535 (1980).
Inturrisi, C.E.; Mitchell, B.M.; Foley, K.M.; Schultz, M.; Shin, S.-U.; Honde, R.W.P.: The pharmacokinetics of heroin in patients with chronic pain. New England Journal of Medicine 310: 1213–1217 (1984).
Kampmann, J.P. and Hansen, M.J.: Clinical pharmacokinetics of antithyroid drugs. Clinical Pharmacokinetics 6: 401–428 (1981).
La Du, B.N. and Snady, H.: Esterases of human tissue; in Brodie and Gillette (Eds) Handbook of Experimental Pharmacology Concepts in Biochemical Pharmacology, pp. 447–479 (1971).
Landecker, K.D.; Wellington, J.E.; Thomas, J.H. and Piper, D.W.: Aspirin and related drugs: Their action and uses. Agents and Actions Suppl. 1: 71–79 (1977).
Lee, V.H.L.: Esterase activities in adult rabbit eyes. Journal of Pharmaceutical Sciences 72: 239–244 (1983).
Lehman, H. and Liddell, J.: Genetic variants of human serum pseudoCholinesterase. Progress in Medical Genetics 3: 75–105 (1964).
Levy, G.: Clinical pharmacokinetics of salicylates: A re-assessment. British Journal of Clinical Pharmacology 10: 285S–290S (1980).
Lockridge, O.; Mottershaw-Jackson, N.; Eckerson, H.W. and La Du, B.M: Hydrolysis of diacetyl morphine (heroin) by human serum Cholinesterase. Journal of Pharmacology and Experimental Therapeutics 215: 1–8 (1980).
Lotti, M.; Ketterman, A.; Waskell, L. and Talcott, R.: Meperidine carboxylesterase in mouse and human livers. Biochemical Pharmacology 32: 3735–3738 (1983).
Mandell, A.I.; Steutz, F. and Kitabchi, A.E.: Dipivalyl epinephrine: A new pro-drug in the treatment of glaucoma. Ophthalmology 85: 268–275 (1978).
Means, G.E. and Bender, M.C.: Acetylalion of human serum albumin by p-nitrophenyl acetate. Biochemistry 14: 4989–4994 (1975).
Menguy, R.; Desbaillets, L.; Masters, Y.F. and Okabe, S.: Evidence for sex-linked difference in aspirin metabolism. Nature 239: 102–103 (1972a).
Menguy, R.; Desbaillets, L.; Okabe, S. and Masters, Y.F.: Abnormal aspirin metabolism in patients with cirrhosis and its possible relationship to bleeding in cirrhotics. Annals of Surgery 176: 412–418 (1972b).
Mentlein, R. and Heymann, E.: Hydrolysis of ester- and amidetype drugs by the purified isoenzymes of nonspecific carboxylesterases from rat liver. Biochemical Pharmacology 33: 1243–1248 (1984).
Mirakur, R.K.; Elliott, P. and Lavey, T.D.: Plasma Cholinesterase activity and the duration of suxamethonium apnoea in children. Annals of the Royal College of Surgeons of England 66: 43–45 (1984).
Morikawa, M.; Inoue, M.; Tsuboi, M.; Shomura, T.; Someya, S.: Murata, S.; Umeura, K. and Suguira, M.: A study of esterase — its application to biotransformation of midecamycin derivatives. Journal of Pharmacobio-Dynamics 5: 314–318 (1982).
Morikawa, M.; Inoue, M.; Tsuboi, M. and Suguira, M.: Studies on aspirin esterase of human serum. Japanese Journal of Pharmacology 29: 581–586 (1979).
Myers, C.; Lockridge, O. and La Du, B.N.: Hydrolysis of methyl prednisolone acetate by human serum Cholinesterase. Drug Metabolism and Disposition 10: 279–280 (1982).
Nakashima, T. and Taurog, A.: Rapid conversion of Carbimazole to methimazole in serum. Evidence for an enzymatic mechanism. Clinical Endocrinology 10: 637–638 (1979).
Notari, R.E.: Prodrug design. Pharmacology and Therapeutics 14: 25–53 (1981).
O’Brien, J.R.: Effects of salicylate on human platelets. Lancet 1: 779–783 (1968).
Ohta, N.; Kurono, Y. and Ikeda, K.: Esterase like activity of human serum. Journal of Pharmaceutical Sciences 72: 385–388 (1983).
Owen, J.A. and Nakatsu, K.: Diacetyl morphine (heroin) hydrolases in human blood. Canadian Journal of Physiology and Pharmacology 61: 8705 (1983).
Pannatier, A.; Jenner, P.; Testa, B. and Etter, J.C.: The skin as a drug-metabolising organ. Drug Metabolism Reviews 8(2): 319–343 (1978).
Playfer, J.R.; Eze, L.C.; Bullen, M.F. and Evans, D.A.P.: Genetic polymorphism and interethnic variability of plasma paraoxonase activity. Journal of Medicial Genetics 13: 337–342 (1976).
Rainsford, K.D.; Ford, N.L.V.; Brooks, P.M. and Watson, H.M.: Plasma aspirin esterases in normal individuals, patients with alcoholic liver disease and rheumatoid arthritis. Characterisation and the importance of enzymatic components. European Journal of Clinical Investigation 10: 413–420 (1980).
Rawlins, M.D.; Shuster, S.; Chapman, P.H.; Shaw, V. and O’Neill, V.A.: Drug metabolism in skin. Proceedings of the First World Conference in Clinical Pharmacology (1980).
Rowland, M. and Riegelman, S.: Pharmacokinetics of acetyl salicylic acid and salicylic acid after intravenous administration, in man. Journal of Pharmaceutical Science 57: 1313–1319 (1968).
Rowland, M.; Riegelman, S.; Harris, P.A. and Sholhoff, S.D.: Ab sorption kinetics of aspirin in man following oral administration of an aqueous solution. Journal of Pharmaceutical Science 61: 379–385 (1972).
Rylance, H.J. and Wallace, R.C.: Erythrocyte and plasma aspirin esterase. British Journal of Clinical Pharmacology 12: 436–438 (1981).
Sach, E.S. and Quiroga, E.: The variability of platelet collagen interactions: Its influence on aspirin inhibition of platelet aggregation. Thrombosis and Haemostasis 56: 658–668 (1976).
Scott, E.M. and Wright, R.C.: Purification and substrate specificity of polymorphic forms of esterase D from human erythrocytes. American Journal of Human Genetics 30: 14–18 (1978).
Sedaghat, A. and Ahrens, E.H.: Lack of effect of cholestyramine on the pharmacokinetics of Clofibrate in man. European Journal of Clinical Investigation 5: 177–185 (1975).
Seymour, R.A. and Rawlins, M.D.: The efficacy and pharmacokinetics of aspirin in postoperative dental pain. British Journal of Clinical Pharmacology 13: 807–810 (1982).
Seymour, R.A.; Rawlins, M.D. and Clothier, A.: The efficacy and pharmacokinetics of sodium salicylate in postoperative dental pain. British Journal of Clinical Pharmacology 17: 161–163 (1984c).
Seymour, R.A.; Williams, F.M.; Ward, A. and Rawlins, M.D.: Aspirin metabolism and efficacy in postoperative dental pain. British Journal of Clinical Pharmacology 17: 697–702 (1984a).
Seymour, R.A.; Williams, F.M.; Oxley, A.; Ward, A.; Fearns, M.; Brigham, K.; Rawlins, M.D. and Jones, P.: A comparative study of the effects of aspirin and paracetamol on platelet aggregation and bleeding time. European Journal of Clinical Pharmacology 26: 567–572 (1984b).
Sinkula, A.A. and Yalkowsky, S.J.: Rationale for design of biologically reversible drug derivatives prodrugs. Journal of Pharmaceutical Sciences 64: 181–210 (1975).
Smith, D.A. and Cole, W.J.: Identification of an arylesterase as the enzyme hydrolysing diacetyl morphine (heroin) in human plasma. Biochemical Pharmacology: 367-370 (1976).
Sparkes, R.S.; Murphree, A.L.; Lingua, R.W.; Sparkes, M.C.; Field, L.L.; Funderburk, S.J. and Benedict, W.F.: Gene for hereditary retinoblastoma assigned to human chromosome 13 by linkage to esterase D. Science 219: 971–973 (1983).
Spenney, J.G.: Acetylsalicylic acid hydrolase of gastric mucosa. American Journal of Physiology 234: E606–E610 (1978).
Stoddart, J.C.: The suxamethonium-pseudocholinesterase relationship. British Journal of Anaesthesia 32: 466–469 (1960).
Sutor, A.M.; Bowie, E.J.W. and Owen, C.A.: Effect of aspirin sodium salicylate and acetyl-aminophen on bleeding. Mayo Clinic Proceedings 46: 178–181 (1971).
Tomasova, H.; Nevoral, J.; Pachl, J. and Kincl, V.: Aspirin esterase activity and Reye’s syndrome. Lancet 2: 43 (1984).
Trnavsky, K. and Zachar, M.: Correlation of serum aspirin esterase activity and halflife of salicylic acid. Agents and Actions 5: 549–552 (1975).
Viby-Mogensen, J.: Correlation of succinylcholine duration of action with plasma Cholinesterase activity in subjects with the genotypically normal enzyme. Anaesthesiology 53: 517–20 (1980).
Walker, C.H. and Machness, M.I.: Esterases: Problems of identification and classification. Biochemical Pharmacology 32: 3265–3269 (1983).
Way, E.L.; Kemp, J.W.; Young, J.M. and Grassietti, D.R.: The pharmacological effects of heroin in relationship to its rate of biotransformation. Journal of Pharmacology and Experimental Therapeutics 129: 144–154 (1960).
Way, EX.; Young, J.M. and Kemp, J.W.: Metabolism of heroin and its pharmacological implications. Bulletin on Narcotics 17: 25–33 (1965).
White, K.N. and Hope, D.B.: Identification of aspirinase with one of the carboxyl esterases requiring a thiol group. Biochemical Journal 197: 771–773 (1981).
White, K.N. and Hope, D.B.: Characterisation of aspirin hydrolase of guinea pig liver cytoplasm. Biochemica Biophysica Acta 785: 132–137 (1984a).
White, K.N. and Hope, D.B.: Partial purification and characterisation of a microsomal carboxyl esterase specific for salicylate esters from guinea pig liver. Biochemica Biophysica Acta 785: 138–147 (1984b).
Williams, F.M.; Seymour, R.A.; Ward, A.; Jones, P. and Rawlins, M.D.: Effects of aspirin on bleeding time and platelet aggregation and its relation to plasma aspirin esterase activity. British Journal of Clinical Pharmacology 17: 609P (1984a).
Williams, F.M.; Seymour, R.A.; Ward, A. and Rawlins, M.D.: Contribution of Cholinesterase to the activity of aspirin esterase in plasma. Proceedings of the 9th International Congress of Pharmacology, London (1984b).
Yeh, S.J.: Localisation and characterisation of meperidine esterase of rats. Drug Metabolism and Disposition 10: 319–325 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Williams, F.M. Clinical Significance of Esterases in Man. Clin Pharmacokinet 10, 392–403 (1985). https://doi.org/10.2165/00003088-198510050-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198510050-00002